Clinical and Regulatory Affairs

The Clinical and Regulatory Affairs team at Optellum is responsible for overseeing the development and implementation of clinical strategies to validate the efficacy of the imaging biomarker for lung cancer detection. This team ensures compliance with regulatory standards, manages clinical trials, and collaborates with medical professionals to gather and analyze data, ultimately aiming to secure necessary approvals and facilitate the safe use of their innovative technology in clinical settings.